Wei Yang

机构：University of Electronic Science and Technology of China, Capital Medical University, Anhui Medical University, Center for Children, Sichuan Cancer Hospital, First Affiliated Hospital of Anhui Medical University, Beijing Children’s Hospital · ORCID：0000-0001-6568-3090

发表论文 59 篇 · 总被引 668 次 · h-index 16

代表论文

• Targeted macrophage phagocytosis by Irg1/itaconate axis improves the prognosis of intracerebral hemorrhagic stroke and peritonitis (2024 · EBioMedicine · 被引 51)
• Effects of Antihypertensive Drugs on Cognitive Function in Elderly Patients with Hypertension: A Review (2021 · Aging and Disease · 被引 42)
• Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia With Losing Major Molecular Response as a Definition for Molecular Relapse: A Systematic Review and Meta-Analysis (2019 · Frontiers in Oncology · 被引 42)
• ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population (2020 · BMC Medical Genetics · 被引 29)
• LBA56 ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC) (2020 · Annals of Oncology · 被引 17)
• Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients (2019 · Medicine · 被引 16)